ABN Amro Lowers Core Laboratories (CLB) to Hold

ABN Amro lowered shares of Core Laboratories (NYSE:CLB) from a buy rating to a hold rating in a report published on Tuesday, MarketBeat reports.

Several other brokerages also recently commented on CLB. Royal Bank of Canada set a $110.00 price objective on Core Laboratories and gave the stock a buy rating in a research note on Thursday, December 21st. Zacks Investment Research downgraded Core Laboratories from a hold rating to a sell rating in a research note on Tuesday, November 7th. Loop Capital set a $115.00 price objective on Core Laboratories and gave the stock a buy rating in a research note on Thursday, December 7th. Deutsche Bank assumed coverage on Core Laboratories in a research note on Tuesday, October 10th. They issued a buy rating and a $109.00 price objective for the company. Finally, Cowen set a $100.00 price objective on Core Laboratories and gave the stock a hold rating in a research note on Friday, October 6th. Three research analysts have rated the stock with a sell rating, eight have given a hold rating and four have assigned a buy rating to the company’s stock. The company has an average rating of Hold and a consensus target price of $110.20.

Core Laboratories (NYSE CLB) traded up $0.11 during mid-day trading on Tuesday, reaching $119.10. The company had a trading volume of 318,286 shares, compared to its average volume of 576,613. Core Laboratories has a fifty-two week low of $86.55 and a fifty-two week high of $124.99. The company has a current ratio of 2.18, a quick ratio of 1.81 and a debt-to-equity ratio of 1.53. The firm has a market cap of $5,260.00, a P/E ratio of 68.84 and a beta of 1.56.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings results on Monday, October 23rd. The oil and gas company reported $0.48 earnings per share for the quarter, topping analysts’ consensus estimates of $0.44 by $0.04. Core Laboratories had a return on equity of 52.89% and a net margin of 12.06%. The business had revenue of $166.20 million for the quarter, compared to the consensus estimate of $160.94 million. During the same period in the prior year, the business earned $0.38 EPS. The firm’s revenue for the quarter was up 1.4% on a year-over-year basis. equities analysts predict that Core Laboratories will post 1.99 EPS for the current year.

Several institutional investors have recently modified their holdings of the company. WCM Investment Management CA grew its holdings in shares of Core Laboratories by 2.5% in the third quarter. WCM Investment Management CA now owns 4,542,901 shares of the oil and gas company’s stock valued at $448,385,000 after acquiring an additional 109,726 shares in the last quarter. Vanguard Group Inc. grew its holdings in shares of Core Laboratories by 1.6% in the second quarter. Vanguard Group Inc. now owns 3,672,865 shares of the oil and gas company’s stock valued at $371,950,000 after acquiring an additional 56,807 shares in the last quarter. Kayne Anderson Rudnick Investment Management LLC grew its holdings in shares of Core Laboratories by 19.0% in the third quarter. Kayne Anderson Rudnick Investment Management LLC now owns 2,025,357 shares of the oil and gas company’s stock valued at $199,904,000 after acquiring an additional 323,357 shares in the last quarter. Earnest Partners LLC grew its holdings in shares of Core Laboratories by 6.3% in the third quarter. Earnest Partners LLC now owns 1,951,719 shares of the oil and gas company’s stock valued at $192,635,000 after acquiring an additional 115,982 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its holdings in shares of Core Laboratories by 14.9% in the third quarter. JPMorgan Chase & Co. now owns 935,695 shares of the oil and gas company’s stock valued at $91,904,000 after acquiring an additional 121,553 shares in the last quarter.

COPYRIGHT VIOLATION WARNING: This article was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and reposted in violation of US and international copyright law. The original version of this article can be read at https://www.dispatchtribunal.com/2018/01/12/abn-amro-lowers-core-laboratories-clb-to-hold.html.

About Core Laboratories

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Analyst Recommendations for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply